Is OSIS a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Aviation and border screening replacement demand, with revenue (ttm) at ~$1.81B. The bear case rests on revenue is concentrated in a small number of very large government contracts, so a single program ending, as the Mexico SEDENA work did, can erase tens of millions of quarterly revenue with little notice. Analysts covering it are spread from $270.00 to $320.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Revenue is concentrated in a small number of very large government contracts, so a single program ending, as the Mexico SEDENA work did, can erase tens of millions of quarterly revenue with little notice. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $270.00, +16.1% from the $232.61 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Aviation and border screening replacement demand. Checkpoint computed tomography, checked-baggage systems and cargo and vehicle inspection are on multi-year refresh cycles funded by aviation authorities, customs agencies and defense ministries. The most optimistic analyst target on OSIS is $320.00, +37.6% from the $232.61 price. That figure is only reachable if this thesis works close to its best case.

Revenue is concentrated in a small number of very large government contracts, so a single program ending, as the Mexico SEDENA work did, can erase tens of millions of quarterly revenue with little notice. Margin direction is the live issue: adjusted operating margin fell about 250 basis points year over year in the fiscal 2026 third quarter even as revenue and EPS beat, and the shares dropped roughly 15% on that report. The company has faced repeated allegations around foreign contracts, including a March 2025 Culper Research short report on Mexico revenue recognition and Department of Justice subpoenas, plus an earlier securities case tied to an Albanian concession that was settled; further legal or regulatory action would be a real overhang. Share count is small, near 16 million, which makes the per-share price high and daily moves larger than the market cap alone suggests. Competitors including Smiths Detection, Leidos and state-backed Nuctech compete hard on price in international tenders, and government budget timing can push awards across quarters for reasons that have nothing to do with the product. The most pessimistic published target is $270.00, +16.1% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

OSI Systems makes security screening systems, patient-monitoring devices and optoelectronic components across three segments.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Aviation and border screening replacement demand) stalling in the reported numbers rather than in the narrative, the risk above (revenue is concentrated in a small number of very large government contracts, so a single program ending, as the Mexico SEDENA work did, can erase tens of millions of quarterly revenue with little notice) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Three things under one roof. Rapiscan and AS&E security screening systems for airports, cargo, borders and government facilities, which drive roughly two-thirds of revenue; Spacelabs patient monitoring and cardiology equipment for hospitals; and optoelectronic components plus contract electronics manufacturing, part of which supplies the company's own products.

Partly. Most Security division revenue comes from governments and government-adjacent customers such as airport authorities and customs agencies, and the not-to-exceed award near $235 million for a homeland-defense over-the-horizon radar transmit subsystem pushes it further into defense electronics. It is not a pure prime contractor, since healthcare and optoelectronics still contribute about a third of sales.

Revenue of roughly $453 million and non-GAAP EPS near $2.60 both beat, but adjusted operating margin contracted to about 11.7% from roughly 14.2%, and Mexico security revenue collapsed to about $11 million from about $69 million. The market read profitability and the program roll-off as the more important signal and shares fell roughly 15%.